NTX-0250

N/A

Report date: 2026/04/10 20:01:49
NME

Base Information

Drug NameNTX-0250
Drug Alias NameNTX-0250NTX-250
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccine
Mechanisms of ActionTumor necrosis factor superfamily member 14 modulatorsInterleukin-12 modulators
TargetsTumor necrosis factor superfamily member 14Interleukin-12
Therapy Area/IndicationsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesNutcracker Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNutcracker Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPapillomavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A